Stocks Industrials NIKI

NASDAQ · Industrials

Niki BioSolutions, Inc. (NIKI)

It posted a net loss of $1.4M. At December 31, 2025 it held $3.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 27, 2026.

Watch NIKI in 60 seconds

What Niki BioSolutions, Inc. does

Niki BioSolutions, Inc. is registered with the SEC under industry code SIC 3829 (Measuring & Controlling Devices, NEC). Its shares trade on NASDAQ under the ticker NIKI.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Niki BioSolutions, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 18, 2026
   Shelf registration to sell securities (amended) S-3/A
2. September 14, 2026
   Other event 8-K
3. September 4, 2026
   Executive or director change 8-K
4. August 28, 2026
   Form RW filing RW
5. August 28, 2026
   Shelf registration to sell securities S-3
6. August 21, 2026
   Exhibits 8-K/A
7. August 21, 2026
   Exhibits 8-K
8. August 7, 2026
   Other event 8-K
9. July 24, 2026
   Activist stake (5% or more) SCHEDULE 13D
10. July 20, 2026
    Acquisition or sale completed 8-K

Recent insider filings (Forms 3, 4 and 144): 5, the latest on August 13, 2026. Insider transactions on SEC

Who owns NIKI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: L1 Capital Global Opportunities Master Fund, Ltd. 0% (May 15, 2025); Scoggin International Fund Ltd. 0% (January 10, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NIKI

What does Niki BioSolutions, Inc. do?

Niki BioSolutions, Inc. is registered with the SEC under industry code SIC 3829 (Measuring & Controlling Devices, NEC). Its shares trade on NASDAQ under the ticker NIKI.

Is Niki BioSolutions, Inc. profitable?

No. In fiscal 2025 it reported a net loss of $1.4M.

When did Niki BioSolutions, Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the shelf registration to sell securities (amended) from September 18, 2026.

Similar companies

Compare NIKI with

Compare NIKI with any company

Follow NIKI

Get an email when Niki BioSolutions, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NIKI: get an email when it files

Where the numbers come from

Financial figures are the values Niki BioSolutions, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.